Bluejay Diagnostics, Inc.BJDXEarnings & Financial Report
Nasdaq
BJDX Q3 2022 Key Financial Metrics
Revenue
$0
Gross Profit
$0
Operating Profit
$-2.8M
Net Profit
$-3.0M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.15
Bluejay Diagnostics, Inc. Q3 2022 Financial Summary
Bluejay Diagnostics, Inc. reported revenue of $0 for Q3 2022, with a net profit of $-3.0M (N/A margin). Cost of goods sold was $0, operating expenses totaled $2.8M.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-3.0M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2022 |
Income Statement
| Q2 2022 | Q3 2022 | |
|---|---|---|
| Revenue | $249040 | $0 |
| YoY Growth | 520.9% | N/A |
Balance Sheet
| Q2 2022 | Q3 2022 | |
|---|---|---|
| Assets | $18.1M | $15.7M |
| Liabilities | $1.4M | $1.9M |
| Equity | $16.7M | $13.8M |
Cash Flow
| Q2 2022 | Q3 2022 | |
|---|---|---|
| Operating CF | $-1.7M | $-1.3M |